Indivior looks beyond opioid-addiction treatments with new deal By Reuters

(Reuters) – Opioid-addiction treatment maker Indivior said on Tuesday it was expanding into possible treatments for cannabis-related disorders through an agreement with a French privately held company.

London-listed Indivior has agreed to pay Aelis Farma $30 million upfront under the agreement to work exclusively on an experimental drug which blocks a type of cannabinoid receptor. (https://refini.tv/3g3MREA)